Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.

In this GEN webinar, eight experts discuss collaborative strategies and technological innovations that are shaping the future of malaria drug development.

A comprehensive genetic analysis of nearly one million people has identified 53 lead variants associated with aging-related frailty.

PacBio develops the Platinum Pedigree benchmark, a new standard for accurate characterization of variation in the human genome.

The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...

The fusion of intelligent modeling workflows, PAT, and smart devices will allow biomanufacturers to drastically reduce development costs.

Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...

The new facility will be Asahi Kasei Life Science's fourth spinning plant for hollow-fiber cellulose membrane filters.

The Waltham Innovation Center will complement Aldevron’s established scientific teams in Fargo, ND, and Madison, WI.

Researchers have elucidated structure-activity relationships underlying a key serotonin receptor shown to regulate mood and cognition.